432 results on '"Cecchin, Diego"'
Search Results
2. EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours
3. Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives
4. EANM perspectives for CZT SPECT in brain applications
5. EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
6. Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging
7. The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy
8. EANM position paper: theranostics in brain tumours—the present and the future
9. Correction to: EANM perspectives for CZT SPECT in brain applications
10. Minutes to hours after a nuclear event: available radiation poisoning antidotes and practical considerations on possible urgent approaches
11. Radiomics of spinal muscles: toward a radiological biomarker for allograft rejection in lung transplant
12. The dynamic functional connectivity fingerprint of high-grade gliomas
13. Frontotemporal dementia phenotype in late-onset Huntington disease without chorea
14. Data-driven analysis of regional brain metabolism in behavioral frontotemporal dementia and late-onset primary psychiatric diseases with frontal lobe syndrome: A PET/MRI study
15. Forensic applications of micro-computed tomography: a systematic review
16. Assessment of structural disconnections in gliomas: comparison of indirect and direct approaches
17. Performance evaluation of the 3D-ring cadmium–zinc–telluride (CZT) StarGuide system according to the NEMA NU 1-2018 standard
18. Pediatric Imaging Using PET/MR Imaging
19. Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance
20. FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
21. Correction to: Frontotemporal dementia phenotype in late-onset Huntington disease without chorea
22. The new era of bio-molecular imaging with O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) in neurosurgery of gliomas
23. A comparison of advanced semi-quantitative amyloid PET analysis methods
24. 2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
25. Radiomic features as biomarkers of soft tissue paediatric sarcomas: preliminary results of a PET/MR study
26. Variability of regional glucose metabolism and the topology of functional networks in the human brain
27. Reducing the Gibbs effect in multimodal medical imaging by the Fake Nodes approach
28. Complex oculomotor nerves palsy and incidental ischemic stroke as atypical presentation of giant cell arteritis
29. Impaired cognitive control in patients with brain tumors
30. EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
31. Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
32. The role of the deep convolutional neural network as an aid to interpreting brain [18F]DOPA PET/CT in the diagnosis of Parkinson’s disease
33. PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls
34. The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review
35. Volumetric histograms-based analysis of apparent diffusion coefficients and standard uptake values for the assessment of pediatric sarcoma at staging: preliminary results of a PET/MRI study
36. (+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls
37. PET/MRI in prostate cancer: a systematic review and meta-analysis
38. [18F]FDG PET/MRI in rectal cancer
39. [18F]FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation
40. Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review
41. [18F]FDG PET/MRI versus contrast-enhanced MRI in detecting regional HNSCC metastases
42. Cutting-Edge Strategies for Renal Tumour-like Lesions in Granulomatosis with Polyangiitis: A Systematic Review.
43. Cerebellar and cortical hypometabolism in progressive stimulus-sensitive limb myoclonus in celiac disease
44. 18F-FDG PET/MRI in adult sarcomas
45. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC)
46. Correction to: Complex oculomotor nerves palsy and incidental ischemic stroke as atypical presentation of giant cell arteritis
47. Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
48. 18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature
49. The role of radiological and hybrid imaging for muscle metastases: a systematic review
50. Impact of acquisition count statistics reduction and SUV discretization on PET radiomic features in pediatric 18F-FDG-PET/MRI examinations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.